Orange Book product · Brand (NDA)
ALPHAGAN
BRIMONIDINE TARTRATE
At a glance
Mar 13, 1997
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 13, 1997
29 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
BRIMONIDINE TARTRATE
Strength
0.5%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 020490
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2024LUMIFY PRESERVATIVE FREEBrand (NDA)
NDA 218424 · BAUSCH AND LOMB INC
- 2017LUMIFYBrand (NDA)
NDA 208144 · BAUSCH AND LOMB INC
- 2013MIRVASOBrand (NDA)
NDA 204708 · GALDERMA LABS LP
- 2006QOLIANABrand (NDA)
NDA 021764 · SANDOZ
- 2005ALPHAGAN PBrand (NDA)
NDA 021770 · ABBVIE
- 2001ALPHAGAN PBrand (NDA)
NDA 021262 · ABBVIE
- 1996ALPHAGANBrand (NDA)
NDA 020613 · ALLERGAN
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 218558 · MICRO LABS
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 220398 · MANKIND PHARMA
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 219219 · GLAND
- 2025BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 217599 · UPSHER SMITH LABS
- 2024BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 213215 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
